Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer, February 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 208 articles:
HTML format


 

Single Articles

  1. TANAKA T, Terai Y, Fujiwara S, Tanaka Y, et al
    Neoadjuvant intra-arterial chemotherapy using an original four-lumen double-balloon catheter for locally advanced uterine cervical cancer.
    Oncotarget. 2018;9:37766-37776.
    Abstract    

    Abstract available

  2. SHANSHAN H, Lan X, Xia L, Huang W, et al
    Inhibition of protease-activated receptor-2 induces apoptosis in cervical cancer by inhibiting signal transducer and activator of transcription-3 signaling.
    J Int Med Res. 2019 Jan 30:300060518820440. doi: 10.1177/0300060518820440.
    Abstract    

    Abstract available

  3. KONES R, Rumana U, Arain F
    A General Pathway Model for Improving Health Disparities: Lessons from Community and Cultural Involvement in Improving Cervical Cancer Screening in Vietnamese Women.
    J Clin Med. 2019;8.
    Abstract    

    Abstract available

  4. HURTADO-SALGADO E, Ortiz-Panozo E, Salmeron J, Saavedra-Lara N, et al
    Use of HPV testing in cervical cancer screening services in Mexico, 2008-2018: a nationwide database study.
    Salud Publica Mex. 2018;60:722-733.
    Abstract    

    Abstract available

  5. FERRECCIO C
    [New strategies for the prevention and control of cervical cancer in Chile.]
    Salud Publica Mex. 2018;60:713-721.
    Abstract    

    Abstract available

  6. HERRERO R
    [Elimination of cervical cancer in Latin America].
    Salud Publica Mex. 2018;60:621-623.
    Abstract    



  7. BOSCH FX, Robles C
    HPV-FASTER: Combined strategies of HPV vaccination and HPV screening towards a one visit for cervical cancer preventive campaigns.
    Salud Publica Mex. 2018;60:612-616.
    Abstract    



  8. FRANCO EL
    Prevention of cervical cancer in Latin America: Future challenges and opportunities.
    Salud Publica Mex. 2018;60:609-611.
    Abstract    



  9. YAN SP, Chu DX, Qiu HF, Xie Y, et al
    LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
    J Cell Mol Med. 2019 Jan 29. doi: 10.1111/jcmm.14161.
    Abstract    

    Abstract available

  10. FU Y, Meng Y, Gu X, Tian S, et al
    miR-503 expression is downregulated in cervical cancer and suppresses tumor growth by targeting AKT2.
    J Cell Biochem. 2019 Jan 29. doi: 10.1002/jcb.28099.
    Abstract    

    Abstract available


  11. Erratum: Securidaca-saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells [Corrigendum].
    Cancer Manag Res. 2019;11:691.
    Abstract    

    Abstract available

  12. AVILA-IBARRA LR, Mora-Garcia ML, Garcia-Rocha R, Hernandez-Montes J, et al
    Mesenchymal stromal cells derived from normal cervix and cervical cancer tumors increase CD73 expression in cervical cancer cells through TGF-beta1 production.
    Stem Cells Dev. 2019 Jan 30. doi: 10.1089/scd.2018.0183.
    Abstract    

    Abstract available

  13. CORDOVA-RIVAS S, Fraire-Soto I, Mercado-Casas Torres A, Servin-Gonzalez LS, et al
    5p and 3p Strands of miR-34 Family Members Have Differential Effects in Cell Proliferation, Migration, and Invasion in Cervical Cancer Cells.
    Int J Mol Sci. 2019;20.
    Abstract    

    Abstract available

  14. SHEN DH
    [Pathologists is indispensable, in screening, diagnosis and therapy of uterine cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:3-6.
    Abstract    



  15. XIA C, He Z, Liang S, Chen R, et al
    Metformin combined with nelfinavir induces SIRT3/mROS - dependent autophagy in human cervical cancer cells and xenograft in nude mice.
    Eur J Pharmacol. 2019 Jan 26. pii: S0014-2999(19)30065.
    Abstract    

    Abstract available

  16. FERREIRA DA SILVA I, Ferreira da Silva I, Koifman RJ
    Cervical Cancer Treatment Delays and Associated Factors in a Cohort of Women From a Developing Country.
    J Glob Oncol. 2019;:1-11.
    Abstract    

    Abstract available

  17. SINGH J, Roy B, Yadav A, Siddiqui S, et al
    Cervical cancer awareness and HPV vaccine acceptability among females in Delhi: A cross-sectional study.
    Indian J Cancer. 2018;55:233-237.
    Abstract    

    Abstract available

  18. GRABAR S, Hleyhel M, Belot A, Bouvier AM, et al
    Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS)
    HIV Med. 2019 Jan 28. doi: 10.1111/hiv.12703.
    Abstract    

    Abstract available

  19. JHAMAD S, Aanjane R, Jaiswal S, Jain S, et al
    Second Primary Cancer after Radiotherapy for Cervical Cancer.
    J Midlife Health. 2018;9:207-209.
    Abstract    

    Abstract available

  20. BERGGRUND M, Enroth S, Lundberg M, Assarsson E, et al
    Identification of candidate plasma protein biomarkers for cervical cancer using the multiplex proximity extension assay.
    Mol Cell Proteomics. 2019 Jan 28. pii: RA118.001208.
    Abstract    

    Abstract available

  21. QIU F, Chen F, Liu D, Xu J, et al
    [LC-MS/MS-based screening of new protein biomarkers for cervical precancerous lesions and cervical cancer].
    Nan Fang Yi Ke Da Xue Xue Bao. 2019;39:13-22.
    Abstract    

    Abstract available

  22. VARAN C, Sen M, Sandler N, Aktas Y, et al
    Mechanical characterization and ex vivo evaluation of anticancer and antiviral drug printed bioadhesive film for the treatment of cervical cancer.
    Eur J Pharm Sci. 2019 Jan 25. pii: S0928-0987(19)30044.
    Abstract    

    Abstract available

  23. LI S, Ren B, Yue S, Gao H, et al
    Notch1 inhibition enhances DNA damage induced by cisplatin in cervical cancer.
    Exp Cell Res. 2019 Jan 25. pii: S0014-4827(19)30020.
    Abstract    

    Abstract available

  24. LI J, Chu ZP, Han H, Zhang Y, et al
    Suppression of miR-93-5p inhibits high-risk HPV-positive cervical cancer progression via targeting of BTG3.
    Hum Cell. 2019 Jan 28. pii: 10.1007/s13577-018-00225.
    Abstract    

    Abstract available

  25. SAUER G, Kurzeder C, Schneider A
    [Impact of surgical approach on prognosis in early-stage cervical cancer].
    Strahlenther Onkol. 2019 Jan 28. pii: 10.1007/s00066-019-01426.
    Abstract    



  26. SANTAMARIA-ULLOA C, Valverde-Manzanares C
    Inequality in the Incidence of Cervical Cancer: Costa Rica 1980-2010.
    Front Oncol. 2019;8:664.
    Abstract    

    Abstract available

  27. SWAIN D, Parida SP
    Preparedness of Young Girls for Prevention of Cervical Cancer and Strategy to introduce the HPV Vaccine.
    Indian J Community Med. 2018;43.
    Abstract    

    Abstract available

  28. ABD EL-KARIM SS, Syam YM, El Kerdawy AM, Abdelghany TM, et al
    New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies.
    Bioorg Chem. 2019;86:80-96.
    Abstract    

    Abstract available

  29. DE FOUCHER T, Bendifallah S, Ouldamer L, Bricou A, et al
    Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group.
    Eur J Surg Oncol. 2018 Dec 30. pii: S0748-7983(18)32012.
    Abstract    

    Abstract available

  30. ROCA AM, Chobrutskiy BI, Callahan BM, Blanck G, et al
    T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival rates.
    Hum Immunol. 2019 Jan 23. pii: S0198-8859(18)31053.
    Abstract    

    Abstract available

  31. LE D, Aldoory L, Garza MA, Fryer CS, et al
    A Spiritually-Based Text Messaging Program to Increase Cervical Cancer Awareness Among African American Women: Design and Development of the CervixCheck Pilot Study.
    JMIR Form Res. 2018;2:e5.
    Abstract    

    Abstract available

  32. CASTLE PE, Pierz A
    (At Least) Once in Her Lifetime: Global Cervical Cancer Prevention.
    Obstet Gynecol Clin North Am. 2019;46:107-123.
    Abstract    

    Abstract available

  33. ZHANG SS, Ding T, Cui ZH, Lv Y, et al
    Efficacy of robotic radical hysterectomy for cervical cancer compared with that of open and laparoscopic surgery: A separate meta-analysis of high-quality studies.
    Medicine (Baltimore). 2019;98:e14171.
    Abstract    

    Abstract available


  34. NewsCAP: Studies question the minimally invasive approach for treating cervical cancer.
    Am J Nurs. 2019;119:14.
    Abstract    



  35. DONG P, Xiong Y, Yu J, Chen L, et al
    Correction: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer.
    Oncogene. 2019 Jan 24. pii: 10.1038/s41388-019-0677.
    Abstract    

    Abstract available

  36. PESOLA F, Sasieni P
    Impact of screening on cervical cancer incidence in England: a time trend analysis.
    BMJ Open. 2019;9:e026292.
    Abstract    

    Abstract available

  37. TAREKEGN AA, Yismaw AE
    Health professionals' willingness to pay and associated factors for human papilloma virus vaccination to prevent cervical cancer at College of Medicine and Health Sciences University of Gondar, Northwest Ethiopia.
    BMC Res Notes. 2019;12:58.
    Abstract    

    Abstract available

  38. FUJIWARA H, Suzuki M, Morisawa H, Sayama M, et al
    The Impact of Triage for Atypical Squamous Cells of Undetermined Significance with Human Papillomavirus Testing in Cervical Cancer Screening in Japan
    Asian Pac J Cancer Prev. 2019;20:81-85.
    Abstract    

    Abstract available

  39. AKAABOUNE M, Kenfack B, Viviano M, Temogne L, et al
    Clearance and persistence of the human papillomavirus infection among Cameroonian women.
    Womens Health (Lond). 2018;14:1745506518805642.
    Abstract    

    Abstract available

  40. ASAKA S, Nakajima T, Momose M, Miyamoto T, et al
    Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
    Virchows Arch. 2019;474:79-86.
    Abstract    

    Abstract available

  41. MUNOZ-BELLO JO, Olmedo-Nieva L, Castro-Munoz LJ, Manzo-Merino J, et al
    HPV-18 E6 Oncoprotein and Its Spliced Isoform E6*I Regulate the Wnt/beta-Catenin Cell Signaling Pathway through the TCF-4 Transcriptional Factor.
    Int J Mol Sci. 2018;19.
    Abstract    

    Abstract available

  42. AKIMOTO T, Takasawa A, Takasawa K, Aoyama T, et al
    Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression.
    Neoplasia. 2018;20:1083-1093.
    Abstract    

    Abstract available

  43. LIU J, Zhen YZ, Cui J, Hu G, et al
    Dynamic influence of Rhein lysinate on HeLa cells.
    Int J Oncol. 2018;53:2047-2055.
    Abstract    

    Abstract available

  44. GANTI AK, Ray J, Mooney KL, Zambrano E, et al
    Unusual Cause of Pediatric Vaginal Bleeding: Infantile Capillary Hemangioma of the Cervix.
    J Pediatr Adolesc Gynecol. 2019;32:80-82.
    Abstract    

    Abstract available

  45. ZHAO W, Wang X, Liang Y
    Application of 64-slice MSCT with ovarian vein tracking technique in identification of suture-fixed transposed ovaries.
    Clin Imaging. 2018;52:113-116.
    Abstract    

    Abstract available

  46. KRINGS A, Duckelmann AM, Moser L, Gollrad J, et al
    Performance of OncoE6 cervical test with collection methods enabling self-sampling.
    BMC Womens Health. 2018;18:68.
    Abstract    

    Abstract available

  47. LEE EK, Lindeman NI, Matulonis UA, Konstantinopoulos PA, et al
    POLE-mutated clear cell cervical cancer associated with in-utero diethylstilbestrol exposure.
    Gynecol Oncol Rep. 2019;28:15-17.
    Abstract    

    Abstract available

  48. SPEES LP, Brewster WR, Varia MA, Weinberger M, et al
    Examining urban and rural differences in how distance to care influences the initiation and completion of treatment among insured cervical cancer patients.
    Cancer Epidemiol Biomarkers Prev. 2019 Feb 7. pii: 1055-9965.EPI-18-0945.
    Abstract    

    Abstract available

  49. PAPADIA A, Morosi C, Wang J, Gasparri ML, et al
    SLN mapping in early-stage cervical cancer as a minimal-invasive triaging tool for multimodal treatment.
    Eur J Surg Oncol. 2019 Jan 30. pii: S0748-7983(19)30209.
    Abstract    

    Abstract available

  50. KAR S, Majumder DD
    A Novel Approach of Mathematical Theory of Shape and Neuro-Fuzzy Based Diagnostic Analysis of Cervical Cancer.
    Pathol Oncol Res. 2019 Feb 6. pii: 10.1007/s12253-019-00582.
    Abstract    

    Abstract available

  51. RODRIGUEZ-ROSALES YE, Salazar-Mejia CE, Soto-Martinez BA, Hernandez-Barajas D, et al
    Cardiac Tamponade as an Initial Manifestation of Cervical Cancer.
    Case Rep Oncol Med. 2019;2019:7524797.
    Abstract    

    Abstract available

  52. HE H, Liu X, Liu Y, Zhang M, et al
    Human papillomavirus E6/E7 and lncRNA TMPOP2 mutually upregulated gene expression in cervical cancer cells.
    J Virol. 2019 Feb 6. pii: JVI.01808-18. doi: 10.1128/JVI.01808.
    Abstract    

    Abstract available

  53. DYER O
    Cervical cancer: deaths increase as HPV vaccine is underused, says WHO.
    BMJ. 2019;364:l580.
    Abstract    



  54. KNAUL FM, Rodriguez NM, Arreola-Ornelas H, Olson JR, et al
    Cervical cancer: lessons learned from neglected tropical diseases.
    Lancet Glob Health. 2019 Feb 1. pii: S2214-109X(18)30533.
    Abstract    



  55. HERNANDEZ SILVA CD, Leal AR, Ortiz-Lazareno PC, Jave Suarez LF, et al
    GPER Overexpression in Cervical Cancer Versus Premalignant Lesions: Its Activation Induces Different forms of Cell Death.
    Anticancer Agents Med Chem. 2019 Feb 6. pii: ACAMC-EPUB-96431.
    Abstract    

    Abstract available

  56. CHEN R, Zhang L
    MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer.
    Anticancer Drugs. 2019 Feb 4. doi: 10.1097/CAD.0000000000000743.
    Abstract    

    Abstract available

  57. MA TM, Harkenrider MM, Yashar CM, Viswanathan AN, et al
    Understanding the underutilization of cervical brachytherapy for locally advanced cervical cancer.
    Brachytherapy. 2019 Feb 2. pii: S1538-4721(18)30566.
    Abstract    

    Abstract available

  58. TABAAC AR, Benotsch EG, Barnes AJ
    Mediation Models of Perceived Medical Heterosexism, Provider-Patient Relationship Quality, and Cervical Cancer Screening in a Community Sample of Sexual Minority Women and Gender Nonbinary Adults.
    LGBT Health. 2019 Feb 5. doi: 10.1089/lgbt.2018.0203.
    Abstract    

    Abstract available

  59. XIA N, Tan WF, Peng QZ, Cai HN, et al
    MiR-374b reduces cell proliferation and cell invasion of cervical cancer through regulating FOXM1.
    Eur Rev Med Pharmacol Sci. 2019;23:513-521.
    Abstract    

    Abstract available

  60. SHAN S, Li HF, Yang XY, Guo S, et al
    Higher lncRNA CASC15 expression predicts poor prognosis and associates with tumor growth in cervical cancer.
    Eur Rev Med Pharmacol Sci. 2019;23:507-512.
    Abstract    

    Abstract available

  61. WANG DW, You D, Dong J, Liu TF, et al
    Knockdown of long non-coding RNA LINC00518 inhibits cervical cancer proliferation and metastasis by modulating JAK/STAT3 signaling.
    Eur Rev Med Pharmacol Sci. 2019;23:496-506.
    Abstract    

    Abstract available

  62. DAI SG, Guo LL, Xia X, Pan Y, et al
    Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer.
    Eur Rev Med Pharmacol Sci. 2019;23:486-495.
    Abstract    

    Abstract available

  63. LI Y, Wang Y, Xie Z, Hu H, et al
    JMJD2A facilitates growth and inhibits apoptosis of cervical cancer cells by downregulating tumor suppressor miR4915p.
    Mol Med Rep. 2019 Jan 31. doi: 10.3892/mmr.2019.9916.
    Abstract    

    Abstract available

  64. ZHANG X, Mao L, Li L, He Z, et al
    Long noncoding RNA GIHCG functions as an oncogene and serves as a serum diagnostic biomarker for cervical cancer.
    J Cancer. 2019;10:672-681.
    Abstract    

    Abstract available

  65. GAO Y, Tang X, Cao J, Rong R, et al
    The Effect of HER2 Single Nucleotide Polymorphisms on Cervical Cancer Susceptibility and Survival in a Chinese Population.
    J Cancer. 2019;10:378-387.
    Abstract    

    Abstract available

  66. OHLMANN CH, Hadaschik B
    Re: Minimally Invasive Versus Abdominal Radical Hysterectomy for Cervical Cancer.
    Eur Urol. 2019 Feb 1. pii: S0302-2838(19)30072.
    Abstract    



  67. GORDON JR, Barve A, Chaudhari V, Kosambiya JK, et al
    "HIV is not an easily acceptable disease": the role of HIV-related stigma in obtaining cervical cancer screening in India.
    Women Health. 2019 Feb 4:1-14. doi: 10.1080/03630242.2019.1565903.
    Abstract    

    Abstract available

  68. SHARMA A, De R, Javed S, Srinivasan R, et al
    Sonic hedgehog pathway activation regulates cervical cancer stem cell characteristics during epithelial to mesenchymal transition.
    J Cell Physiol. 2019 Feb 4. doi: 10.1002/jcp.28231.
    Abstract    

    Abstract available

  69. MALAGON T, Kulasingam S, Franco EL
    Limitations of simulation models for cervical cancer screening - Authors' reply.
    Lancet Oncol. 2019;20:e69.
    Abstract    



  70. HAMMER A, Landy R, Rositch AF, Gravitt PE, et al
    Limitations of simulation models for cervical cancer screening.
    Lancet Oncol. 2019;20:e68.
    Abstract    



  71. MATSUOKA H, Nakamura K, Matsubara Y, Ida N, et al
    Sarcopenia Is Not a Prognostic Factor of Outcome in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy or Radiotherapy.
    Anticancer Res. 2019;39:933-939.
    Abstract    

    Abstract available

  72. UNO T, Kanazawa A, Nemoto MW, Harada R, et al
    Radiation Therapy for Extrapelvic Lymph Node Recurrence After Curative Treatment for Cervical Cancer.
    Anticancer Res. 2019;39:891-895.
    Abstract    

    Abstract available

  73. TRYBUS W, Krol T, Trybus E, Stachurska A, et al
    Emodin Induces Death in Human Cervical Cancer Cells Through Mitotic Catastrophe.
    Anticancer Res. 2019;39:679-686.
    Abstract    

    Abstract available

  74. THI NGUYEN DN, Simms K, Vu Nguyen HQ, Van Tran T, et al
    The burden of cervical cancer in Vietnam: Synthesis of the evidence.
    Cancer Epidemiol. 2019;59:83-103.
    Abstract    

    Abstract available

  75. LIU X, Gan L, Zhang J
    miR-543 inhibites cervical cancer growth and metastasis by targeting TRPM7.
    Chem Biol Interact. 2019 Jan 30. pii: S0009-2797(18)31439.
    Abstract    

    Abstract available

  76. ABOUL-SOUD MAM, Al-Amri MZ, Kumar A, Al-Sheikh YA, et al
    Specific Cytotoxic Effects of Parasporal Crystal Proteins Isolated from Native Saudi Arabian Bacillus thuringiensis Strains against Cervical Cancer Cells.
    Molecules. 2019;24.
    Abstract    

    Abstract available

  77. YOU H, Gu H, Zhang N, Fan H, et al
    Why hasn't this woman been screened for breast and cervical cancer? - Evidence from a Chinese population-based study.
    Public Health. 2019;168:83-91.
    Abstract    

    Abstract available

  78. PERVIN S, Ruma FI, Rahman K, Ferdous J, et al
    Adjuvant Hysterectomy in Patients With Residual Disease After Radiation for Locally Advanced Cervical Cancer: A Prospective Longitudinal Study.
    J Glob Oncol. 2019;:1-7.
    Abstract    

    Abstract available

  79. TCHOUNZOU R, Simo Wambo AG, Njamen TN, Ilick IO, et al
    Patients Lost to Follow-Up for Cervical Cancer in the Limbe Regional Hospital.
    J Glob Oncol. 2019;:1-5.
    Abstract    

    Abstract available

  80. GILLANI SW, Zaghloul HA, Ansari IA, Abdul MIM, et al
    Multivariate Analysis on the Effects of Diabetes and related Clinical Parameters on Cervical Cancer Survival Probability.
    Sci Rep. 2019;9:1084.
    Abstract    

    Abstract available

  81. STUMBAR SE, Stevens M, Feld Z
    Cervical Cancer and Its Precursors: A Preventative Approach to Screening, Diagnosis, and Management.
    Prim Care. 2019;46:117-134.
    Abstract    

    Abstract available

  82. MATSUO K, Shimada M, Yamaguchi S, Kigawa J, et al
    Neoadjuvant Chemotherapy with Taxane and Platinum Followed by Radical Hysterectomy for Stage IB2-IIB Cervical Cancer: Impact of Histology Type on Survival.
    J Clin Med. 2019;8.
    Abstract    

    Abstract available

  83. KERN S, Truebenbach I, Hohn M, Gorges J, et al
    Combined antitumoral effects of pretubulysin and methotrexate.
    Pharmacol Res Perspect. 2019;7:e00460.
    Abstract    

    Abstract available

  84. CHOI H, Choe SW
    Acoustic Stimulation by Shunt-Diode Pre-Linearizer using Very High Frequency Piezoelectric Transducer for Cancer Therapeutics.
    Sensors (Basel). 2019;19.
    Abstract    

    Abstract available

  85. XIA X, Xiang X, Huang F, Zheng M, et al
    Dietary canolol induces apoptosis in human cervical carcinoma HeLa cells through ROS-MAPK mediated mitochondrial signaling pathway: In vitro and in vivo.
    Chem Biol Interact. 2019;300:138-150.
    Abstract    

    Abstract available

  86. CARESTIATO FN, Amaro-Filho SM, Moreira MAM, Cavalcanti SMB, et al
    Methylation of p16 ink4a promoter is independent of human papillomavirus DNA physical state: a comparison between cervical pre-neoplastic and neoplastic samples.
    Mem Inst Oswaldo Cruz. 2018;114:e180456.
    Abstract    

    Abstract available

  87. JI X, Chen F, Zhou Y, Li J, et al
    Copy number variation profile in noninvasive prenatal testing (NIPT) can identify co-existing maternal malignancies: Case reports and a literature review.
    Taiwan J Obstet Gynecol. 2018;57:871-877.
    Abstract    

    Abstract available

  88. WANG YC, Yu YL, Fan CW, Huang SY, et al
    Primary signet ring cell carcinoma of the cervix: A case report with review of the literature.
    Taiwan J Obstet Gynecol. 2018;57:862-866.
    Abstract    

    Abstract available

  89. TSAI LY, Lee SC, Wang KL, Tsay SL, et al
    A correlation study of fear of cancer recurrence, illness representation, self-regulation, and quality of life among gynecologic cancer survivors in Taiwan.
    Taiwan J Obstet Gynecol. 2018;57:846-852.
    Abstract    

    Abstract available

  90. WILLEMS B, Bracke P
    The impact of regional screening policies on the diffusion of cancer screening participation in Belgium: time trends in educational inequalities in Flanders and Wallonia.
    BMC Health Serv Res. 2018;18:943.
    Abstract    

    Abstract available

  91. LEITE FMC, Amorim MHC, Gigante DP
    Implication of violence against women on not performing the cytopathologic test.
    Rev Saude Publica. 2018;52:89.
    Abstract    

    Abstract available

  92. SAINEI NE, Kumar VS, Chin YS, Salih FAM, et al
    High Prevalence of Human Papillomavirus Types 56 and 70 Identified in the Native Populations of Sabah, Malaysia
    Asian Pac J Cancer Prev. 2018;19:2807-2813.
    Abstract    

    Abstract available

  93. OKUHARA T, Ishikawa H, Okada M, Kato M, et al
    Amount of Narratives Used on Japanese Pro- and Anti-HPV Vaccination Websites: A Content Analysis
    Asian Pac J Cancer Prev. 2018;19:2691-2694.
    Abstract    

    Abstract available

  94. KREMER WW, van Zummeren M, Heideman DAM, Lissenberg-Witte BI, et al
    HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV.
    Int J Mol Sci. 2018;19.
    Abstract    

    Abstract available

  95. PECORELLA I, Monti M, Dei Malatesta MLF, Ciardi G, et al
    Polyp of the uterine cervix with heterologous fatty tissue.
    Indian J Pathol Microbiol. 2018;61:593-595.
    Abstract    

    Abstract available

  96. HUANG ZY, Zhang S, Zhang YZ, An JH, et al
    The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix.
    Indian J Pathol Microbiol. 2018;61:549-552.
    Abstract    

    Abstract available

  97. ZHANG X, Luo L, Li L, He Y, et al
    Trimodal synergistic antitumor drug delivery system based on graphene oxide.
    Nanomedicine. 2019;15:142-152.
    Abstract    

    Abstract available

  98. RASHMI R, Nedungadi D, Podder A, Mishra N, et al
    Monitoring of topoisomerase (I) inhibitor camptothecin release from endogenous redox-stimulated GO-polymer hybrid carrier.
    J Photochem Photobiol B. 2018;189:14-20.
    Abstract    

    Abstract available

  99. WANG L, Du W, Zhu S, Jiang P, et al
    A high-risk papillomavirus 18 E7 affibody-enabled in vivo imaging and targeted therapy of cervical cancer.
    Appl Microbiol Biotechnol. 2019 Feb 15. pii: 10.1007/s00253-019-09655.
    Abstract    

    Abstract available

  100. CEGLA P, Urbanski B, Burchardt E, Roszak A, et al
    Influence of 18F-FDG-PET/CT on staging of cervical cancer.
    Nuklearmedizin. 2019;58:17-22.
    Abstract    

    Abstract available

  101. MORRIS BJ, Hankins CA, Banerjee J, Lumbers ER, et al
    Does Male Circumcision Reduce Women's Risk of Sexually Transmitted Infections, Cervical Cancer, and Associated Conditions?
    Front Public Health. 2019;7:4.
    Abstract    

    Abstract available

  102. LI J, Liu C, Li D, Wan M, et al
    OLFM4 inhibits epithelial-mesenchymal transition and metastatic potential of cervical cancer cells.
    Oncol Res. 2019 Feb 14. doi: 10.3727/096504018X15399955297355.
    Abstract    

    Abstract available

  103. NGO-METZGER Q, Adsul P
    Screening for Cervical Cancer.
    Am Fam Physician. 2019;99:253-254.
    Abstract    




  104. Screening for Cervical Cancer: Recommendation Statement.
    Am Fam Physician. 2019;99:Online.
    Abstract    



  105. DOU PH, Zhang DF, Su CH, Zhang XL, et al
    Electrical stimulation on adverse events caused by chemotherapy in patients with cervical cancer: A protocol for a systematic review of randomized controlled trial.
    Medicine (Baltimore). 2019;98:e14609.
    Abstract    

    Abstract available

  106. LIU H, Liu L, Zhu H
    The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
    J Comput Biol. 2019 Feb 14. doi: 10.1089/cmb.2018.0241.
    Abstract    

    Abstract available

  107. YU J, Zhang J, Zhou L, Li H, et al
    The Octamer-Binding Transcription Factor 4 (OCT4) Pseudogene, POU Domain Class 5 Transcription Factor 1B (POU5F1B), is Upregulated in Cervical Cancer and Down-Regulation Inhibits Cell Proliferation and Migration and Induces Apoptosis in Cervical Cance
    Med Sci Monit. 2019;25:1204-1213.
    Abstract    

    Abstract available

  108. ROSA MN, Evangelista AF, Leal LF, De Oliveira CM, et al
    Establishment, molecular and biological characterization of HCB-514: a novel human cervical cancer cell line.
    Sci Rep. 2019;9:1913.
    Abstract    

    Abstract available

  109. RANDALL TC, Sauvaget C, Muwonge R, Trimble EL, et al
    Authors response to Papoutsis and colleagues letter to the editor regarding: Worthy of further consideration: An updated meta-analysis to address the feasibility, acceptability, safety and efficacy of thermal ablation in the treatment of cervical canc
    Prev Med. 2019 Feb 10. pii: S0091-7435(19)30027.
    Abstract    



  110. OTERO-GARCIA MM, Mesa-Alvarez A, Nikolic O, Blanco-Lobato P, et al
    Role of MRI in staging and follow-up of endometrial and cervical cancer: pitfalls and mimickers.
    Insights Imaging. 2019;10:19.
    Abstract    

    Abstract available

  111. WU Y, Li H, Wang H, Zhang F, et al
    MSK2 promotes proliferation and tumor formation in squamous cervical cancer via PAX8/RB-E2F1/cyclin A2 axis.
    J Cell Biochem. 2019 Feb 12. doi: 10.1002/jcb.28421.
    Abstract    

    Abstract available

  112. SNIADECKI M, Wydra DG, Wojtylak S, Wycinka E, et al
    The impact of low volume lymph node metastases and stage migration after pathologic ultrastaging of non-sentinel lymph nodes in early-stage cervical cancer: a study of 54 patients with 4.2 years of follow up.
    Ginekol Pol. 2019;90:20-30.
    Abstract    

    Abstract available

  113. HEEREN AM, Rotman J, Stam AGM, Pocorni N, et al
    Efficacy of PD-1 blockade in cervical cancer is related to a CD8(+)FoxP3(+)CD25(+) T-cell subset with operational effector functions despite high immune checkpoint levels.
    J Immunother Cancer. 2019;7:43.
    Abstract    

    Abstract available

  114. WILLIAM W, Ware A, Basaza-Ejiri AH, Obungoloch J, et al
    A pap-smear analysis tool (PAT) for detection of cervical cancer from pap-smear images.
    Biomed Eng Online. 2019;18:16.
    Abstract    

    Abstract available

  115. CURRY SJ, Krist AH, Owens DK
    Age of Initiation of Cervical Cancer Screening-Reply.
    JAMA. 2019;321:612.
    Abstract    

    Abstract available

  116. DICKINSON JA
    Age of Initiation of Cervical Cancer Screening.
    JAMA. 2019;321:611-612.
    Abstract    



  117. KIETPEERAKOOL C, Aue-Aungkul A, Galaal K, Ngamjarus C, et al
    Nerve-sparing radical hysterectomy compared to standard radical hysterectomy for women with early stage cervical cancer (stage Ia2 to IIa).
    Cochrane Database Syst Rev. 2019;2:CD012828.
    Abstract    

    Abstract available

  118. YAZGHICH I, Berraho M
    Cervical cancer in the Maghreb country (Morocco - Algeria - Tunisia) : epidemiological, clinical profile and control policy.
    Tunis Med. 2018;96.
    Abstract    

    Abstract available

  119. PERGIALIOTIS V, Bellos I, Thomakos N, Haidopoulos D, et al
    Survival outcomes of patients with cervical cancer and accompanying hydronephrosis: A systematic review of the literature.
    Oncol Rev. 2019;13:387.
    Abstract    

    Abstract available

  120. UTAMI S, Purwani W
    Increasing mothers' knowledge of cervical cancer risk through peer group health education with "PinKa" method.
    Enferm Clin. 2019 Feb 7. pii: S1130-8621(19)30018.
    Abstract    

    Abstract available

  121. YANG Y, Che Y, Zhao Y, Wang X, et al
    Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivo.
    Int Immunopharmacol. 2019;69:279-288.
    Abstract    

    Abstract available

  122. FERRIS DG, Chen J, Isaac A, Braithwaite E, et al
    Reimbursement Incentives to Improve Adherence to Follow-Up of Cervical Cancer Cytology Screening Results in Peru.
    J Low Genit Tract Dis. 2019 Feb 7. doi: 10.1097/LGT.0000000000000459.
    Abstract    

    Abstract available

  123. PYEON SY, Hur YJ, Lee JM
    Rethinking the next step after unexpected results associated with minimally invasive radical hysterectomy for early cervical cancer.
    J Gynecol Oncol. 2019 Jan 3. pii: 30.e43. doi: 10.3802/jgo.2019.
    Abstract    



  124. BOGANI G, Rossetti D, Ditto A, Martinelli F, et al
    Minimally invasive surgery improves short-term outcomes of nerve-sparing radical hysterectomy in patients with cervical cancer: a propensity-matched analysis with open abdominal surgery.
    J Gynecol Oncol. 2018 Nov 27. pii: 30.e27. doi: 10.3802/jgo.2019.
    Abstract    

    Abstract available

  125. FENG LL, Shen FR, Zhou JH, Chen YG, et al
    Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
    Gene. 2019 Feb 7. pii: S0378-1119(19)30075-7. doi: 10.1016/j.gene.2019.
    Abstract    

    Abstract available

  126. JODDA A, Piotrowski T, Urbanski B, Malicki J, et al
    Relations between dose cumulated in organs at risk and treatment based on different image-guidance strategies of cervical cancer.
    Phys Med. 2019;57:183-190.
    Abstract    

    Abstract available

  127. CLIFFORD GM, Tenet V, Georges D, Alemany L, et al
    Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women.
    Papillomavirus Res. 2019;7:67-74.
    Abstract    

    Abstract available

  128. POETSCH N, Sturdza A, Aust S, Polterauer S, et al
    The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy.
    Strahlenther Onkol. 2019 Feb 8. pii: 10.1007/s00066-019-01430.
    Abstract    

    Abstract available

  129. SULLIVAN SA, Stringer E, Van Le L
    A Review of Gynecologic Oncology in the Global Setting: Educating and Training the Next Generation of Women's Health Providers.
    Obstet Gynecol Surv. 2019;74:40-49.
    Abstract    

    Abstract available

  130. ZHANG J, Wang YC, Yu XD, Tian Y, et al
    [Role of Magnetic Resonance Imaging in distinguishing the origin of adenocarcinoma at the junction of the lower uterine segment and endocervix].
    Zhonghua Zhong Liu Za Zhi. 2018;40:912-916.
    Abstract    

    Abstract available

  131. HE Y, Zhao H, Li XM, Yin CH, et al
    Use of mesothelin as a tumor-associated antigen in cervical squamous cell carcinoma.
    Gene. 2019;690:30-37.
    Abstract    

    Abstract available

  132. PECCATTE E, Vallee J, Trombert B, Savall A, et al
    [Evaluation of 114 abnormal Pap smear follow-up in ambulatory care.]
    Sante Publique. 2018;30:527-532.
    Abstract    

    Abstract available

  133. XIA Y, Xu T, Zhao M, Hua L, et al
    Delivery of Doxorubicin for Human Cervical Carcinoma Targeting Therapy by Folic Acid-Modified Selenium Nanoparticles.
    Int J Mol Sci. 2018;19.
    Abstract    

    Abstract available

  134. LIU ZH, Lin W, Wang YY, Wu B, et al
    [Risk stratification of type-specific human papillomavirus for cervical precancers: evidence from a cross-sectional study in Shenzhen].
    Zhonghua Zhong Liu Za Zhi. 2018;40:757-763.
    Abstract    

    Abstract available

  135. JIANG MY, Feng RM, Wang L, Li TY, et al
    [Performance of combined liquid based cytology and HPV nucleic acid test for detecting cervical precancer among women attending screening].
    Zhonghua Zhong Liu Za Zhi. 2018;40:750-756.
    Abstract    

    Abstract available

  136. TIAN YB, Zhang CT
    [Molecular detection and genotyping of human papillomavirus].
    Zhonghua Zhong Liu Za Zhi. 2018;40:729-735.
    Abstract    

    Abstract available

  137. ZHANG L, Zhao FH
    [Research progression of prophylactic HPV vaccine application].
    Zhonghua Zhong Liu Za Zhi. 2018;40:724-728.
    Abstract    

    Abstract available

  138. WILSON E, Janssens S, Ng D, Jolly B, et al
    Trainee Performance in Loop Electrosurgical Excision Procedure (LEEP) After Simulation Training.
    J Low Genit Tract Dis. 2019;23:28-32.
    Abstract    

    Abstract available

  139. CHEN L, Liu L, Tao X, Guo L, et al
    Risk Factor Analysis of Persistent High-Grade Squamous Intraepithelial Lesion After Loop Electrosurgical Excision Procedure Conization.
    J Low Genit Tract Dis. 2019;23:24-27.
    Abstract    

    Abstract available

  140. HU Y, Zeng F
    [Expressions of GPR81, MCT1 and MCT4 in squamous carcinoma and their clinical significance].
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43:950-956.
    Abstract    

    Abstract available

  141. DEHLENDORFF C, Sparen P, Baldur-Felskov B, Herweijer E, et al
    Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions.
    Vaccine. 2018 Sep 18. pii: S0264-410X(18)31258.
    Abstract    

    Abstract available

  142. HILLEMANNS P, Friese K, Dannecker C, Klug S, et al
    Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up.
    Geburtshilfe Frauenheilkd. 2019;79:160-176.
    Abstract    

    Abstract available

  143. HILLEMANNS P, Friese K, Dannecker C, Klug S, et al
    Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
    Geburtshilfe Frauenheilkd. 2019;79:148-159.
    Abstract    

    Abstract available

  144. HILLEMANNS P, Brucker S, Holthaus B, Kimmig R, et al
    Updated Opinion of the Uterus Commission of the Gynecological Oncology Working Group (AGO) and the Gynecological Endoscopy Working Group (AGE) of the German Society of Gynecology and Obstetrics (DGGG) on the Randomized Study Comparing Minimally Invasi
    Geburtshilfe Frauenheilkd. 2019;79:145-147.
    Abstract    

    Abstract available

  145. LIU S, Meng F, Ding J, Ji H, et al
    High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer.
    Biosci Rep. 2019 Feb 21. pii: BSR20181639. doi: 10.1042/BSR20181639.
    Abstract    

    Abstract available

  146. WANG L, Liu Y, Zhou Y, Wang J, et al
    Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
    J Exp Clin Cancer Res. 2019;38:93.
    Abstract    

    Abstract available

  147. XU Y, Zhou W, Zhang C, Liu X, et al
    Long non-coding RNA RP11-552M11.4 favors tumorigenesis and development of cervical cancer via modulating miR-3941/ATF1 signaling.
    Int J Biol Macromol. 2019 Feb 18. pii: S0141-8130(18)36758.
    Abstract    

    Abstract available

  148. PERRONE AM, Bovicelli A, D'Andrilli G, Borghese G, et al
    Cervical cancer in pregnancy: Analysis of the literature and innovative approaches.
    J Cell Physiol. 2019 Feb 20. doi: 10.1002/jcp.28340.
    Abstract    

    Abstract available

  149. GUAN YH, Tian M, Liu XY, Wang YN, et al
    Preparation of novel cisplatin-conjugated hollow gold nanospheres for targeting cervical cancer.
    J Cell Physiol. 2019 Feb 20. doi: 10.1002/jcp.28316.
    Abstract    

    Abstract available

  150. GIL-MORENO A, Magrina JF
    Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer.
    N Engl J Med. 2019;380:794.
    Abstract    



  151. CHIVA L, Cibula D, Querleu D
    Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer.
    N Engl J Med. 2019;380:793-4.
    Abstract    



  152. TAKAHASHI Y, Matsushima H, Mori T, Kokabu T, et al
    Retroperitoneal fibrosis after chemo-radiotherapy for cervical cancer: A case report.
    J Obstet Gynaecol Res. 2019 Feb 20. doi: 10.1111/jog.13898.
    Abstract    

    Abstract available

  153. RICHARDS C, Thomas-Purcell KB, Vemulapalli KC, Primus-Joseph M, et al
    Woman to Woman: Implementation of a Cervical Cancer Education Training Program for Grenadian Lay Health Advisors.
    J Cancer Educ. 2019 Feb 20. pii: 10.1007/s13187-019-01495.
    Abstract    

    Abstract available

  154. KATO H, Esaki K, Yamaguchi T, Tanaka H, et al
    Predicting Early Response to Chemoradiotherapy for Uterine Cervical Cancer Using Intravoxel Incoherent Motion MR Imaging.
    Magn Reson Med Sci. 2019 Feb 19. doi: 10.2463/mrms.tn.2018-0138.
    Abstract    

    Abstract available


  155. International Federation of Gynecology and Obstetrics Global Declaration on Cervical Cancer Elimination.
    Rev Bras Ginecol Obstet. 2019;41:102-103.
    Abstract    



  156. CAIN JM
    Answering the Call to Accelerate the Elimination of Cervical Cancer.
    Rev Bras Ginecol Obstet. 2019;41:67.
    Abstract    



  157. RAMIREZ PT, Obermair A
    Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer. Reply.
    N Engl J Med. 2019;380:794-795.
    Abstract    



  158. ABDOLLAH F, Keeley J, Menon M
    Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer.
    N Engl J Med. 2019;380:793.
    Abstract    



  159. XIONG Y, Li T, Assani G, Ling H, et al
    Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo.
    Biomed Pharmacother. 2019;112:108602.
    Abstract    

    Abstract available

  160. CHAUDHARY M, Kumar N, Baldi A, Chandra R, et al
    Chloro and Bromo-Pyrazole Curcumin Knoevenagel Condensates augmented Anticancer activity against Human Cervical Cancer Cells: Design, Synthesis, In silico Docking and In Vitro Cytotoxicity Analysis.
    J Biomol Struct Dyn. 2019 Feb 20:1-24. doi: 10.1080/07391102.2019.1578264.
    Abstract    

    Abstract available

  161. ZHANG Q, Yang D
    Allicin suppresses the migration and invasion in cervical cancer cells mainly by inhibiting NRF2.
    Exp Ther Med. 2019;17:1523-1528.
    Abstract    

    Abstract available

  162. SRIVASTAVA AN, Misra JS, Srivastava S, Das BC, et al
    Cervical cancer screening in rural India: Status & current concepts.
    Indian J Med Res. 2018;148:687-696.
    Abstract    

    Abstract available

  163. VLIET-GREGG PA, Robinson KL, Levan J, Matsumoto LR, et al
    NFX1-123 is highly expressed in cervical cancer and increases growth and telomerase activity in HPV 16E6 expressing cells.
    Cancer Lett. 2019 Feb 15. pii: S0304-3835(19)30102.
    Abstract    

    Abstract available

  164. LIU Y, Wu L, Tong R, Yang F, et al
    PD-1/PD-L1 Inhibitors in Cervical Cancer.
    Front Pharmacol. 2019;10:65.
    Abstract    

    Abstract available

  165. ZHAO L, Zheng Y, Ji Y, Zhang X, et al
    The expression of special AT-rich binding protein 1 in cervical cancer and its clinical significance.
    Onco Targets Ther. 2019;12:945-951.
    Abstract    

    Abstract available

  166. RODRIGUES C, Pattabiraman C, Vijaykumar A, Arora R, et al
    A SUV39H1-low chromatin state characterises and promotes migratory properties of cervical cancer cells.
    Exp Cell Res. 2019 Feb 14. pii: S0014-4827(18)30986.
    Abstract    

    Abstract available

  167. SPAMPINATO S, Fokdal L, Marinovskij E, Axelsen S, et al
    Assessment of dose to functional sub-structures in the lower urinary tract in locally advanced cervical cancer radiotherapy.
    Phys Med. 2019 Feb 13. pii: S1120-1797(19)30017.
    Abstract    

    Abstract available

  168. NAKAO KK, Kido A, Imai T, Abiko K, et al
    Frequency and risk factors of thoracic metastases and optimisation of the use of cross-sectional chest imaging in follow-up patients with cervical cancer.
    Clin Radiol. 2019 Feb 13. pii: S0009-9260(19)30062.
    Abstract    

    Abstract available

  169. PRICE S
    Talk to Patients About: HPV.
    Tex Med. 2018;114:46.
    Abstract    

    Abstract available

  170. LI X, Cai Y
    Methylation-Based Classification of Cervical Squamous Cell Carcinoma into Two New Subclasses Differing in Immune-Related Gene Expression.
    Int J Mol Sci. 2018;19.
    Abstract    

    Abstract available

  171. HOLZHAUSER C, Da Rosa P, Michael S
    Forecasting Participants in the All Women Count! Mammography Program.
    Prev Chronic Dis. 2018;15:E130.
    Abstract    

    Abstract available

  172. CASARIN J, Multinu F, Pasupathy K, Weaver A, et al
    Frozen Section for Detection of Lymph Nodes After Cervical Injection with Indocyanine Green (ICG) for Sentinel Lymph Node Technique in Endometrial Cancer Staging.
    Ann Surg Oncol. 2018;25:3692-3698.
    Abstract    

    Abstract available

  173. SKUFCA J, Ollgren J, Artama M, Ruokokoski E, et al
    The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.
    Vaccine. 2018 Jul 25. pii: S0264-410X(18)30925.
    Abstract    

    Abstract available

  174. LIANG Y, Lu B, Zhou C
    Cervical Adenoid Basal Carcinoma: Clinicopathologic Features of 9 Cases With Reference to CK17 and Ki-67 Expression.
    J Low Genit Tract Dis. 2019;23:77-81.
    Abstract    

    Abstract available

  175. EASTERLY CW, Alarid-Escudero F, Enns EA, Kulasingam S, et al
    Revisiting assumptions about age-based mixing representations in mathematical models of sexually transmitted infections.
    Vaccine. 2018;36:5572-5579.
    Abstract    

    Abstract available

  176. DEMARQUET E, Mancini J, Preaubert L, Gondry J, et al
    Risk Factors of Post-Large Loop Excision of the Transformation Zone Recurrent High-Grade Cervical Intraepithelial Lesion: A Prospective Cohort Study.
    J Low Genit Tract Dis. 2019;23:18-23.
    Abstract    

    Abstract available

  177. HAN C, Yu W, Zheng X, Zhou Y, et al
    Composite QA for intensity-modulated radiation therapy using individual volume-based 3D gamma indices.
    J Radiat Res. 2018;59:669-676.
    Abstract    

    Abstract available

  178. LYNGE E, Skorstengaard M, Lubker CL, Thamsborg L, et al
    HPV-vaccination impact in Denmark: is the vaccine working?
    Expert Rev Vaccines. 2018;17:765-767.
    Abstract    



  179. WUSTENHAGEN E, Boukhallouk F, Negwer I, Rajalingam K, et al
    The Myb-related protein MYPOP is a novel intrinsic host restriction factor of oncogenic human papillomaviruses.
    Oncogene. 2018;37:6275-6284.
    Abstract    

    Abstract available

  180. WOLFF E, Elfstrom KM, Haugen Cange H, Larsson S, et al
    Cost-effectiveness of sex-neutral HPV-vaccination in Sweden, accounting for herd-immunity and sexual behaviour.
    Vaccine. 2018 Jul 14. pii: S0264-410X(18)30948.
    Abstract    

    Abstract available

  181. ABOLAFIA-CANETE B, Monserrat-Jordan JA, Cuevas-Cruces J, Arjona-Berral JE, et al
    [Early diagnosis of cervix cancer: Correlation between cytology, colposcopy and biopsy].
    Rev Esp Patol. 2018;51:147-153.
    Abstract    

    Abstract available

  182. MAI YH, Kong FT, Yang YW, Li YB, et al
    [Constraint priority list-based multi-objective optimization for intensity-modulated radiation therapy].
    Nan Fang Yi Ke Da Xue Xue Bao. 2018;38:691-697.
    Abstract    

    Abstract available

  183. OBAHIAGBON U, Smith JT, Zhu M, Katchman BA, et al
    A compact, low-cost, quantitative and multiplexed fluorescence detection platform for point-of-care applications.
    Biosens Bioelectron. 2018;117:153-160.
    Abstract    

    Abstract available

  184. LI W, Shi D, Jia R, Yang J, et al
    [Selection of DNA aptamers to cervical intraepithelial neoplasia by SELEX].
    Sheng Wu Gong Cheng Xue Bao. 2018;34:785-793.
    Abstract    

    Abstract available

  185. WALCH-RUCKHEIM B, Stroder R, Theobald L, Pahne-Zeppenfeld J, et al
    Cervical cancer-instructed stromal fibroblasts enhance IL-23 expression in dendritic cells to support expansion of Th17 cells.
    Cancer Res. 2019 Jan 29. pii: 0008-5472.CAN-18-1913.
    Abstract    

    Abstract available

  186. HESCOT S, Haissaguerre M, Pautier P, Kuhn E, et al
    Immunotherapy-induced Addison's disease: A rare, persistent and potentially lethal side-effect.
    Eur J Cancer. 2018;97:57-58.
    Abstract    



  187. CIAVATTINI A, Serri M, Di Giuseppe J, Liverani CA, et al
    Reliability of colposcopy during pregnancy.
    Eur J Obstet Gynecol Reprod Biol. 2018;229:76-81.
    Abstract    

    Abstract available

  188. QUEIROZ ACM, Fabri V, Mantoan H, Sanches SM, et al
    Risk factors for pelvic and distant recurrence in locally advanced cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2019;235:6-12.
    Abstract    

    Abstract available

  189. VASSILAKOS P, Poncet A, Catarino R, Viviano M, et al
    Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in cervical cancer screening in Switzerland.
    Gynecol Oncol. 2019 Feb 1. pii: S0090-8258(19)30064.
    Abstract    

    Abstract available

  190. HUTCHCRAFT ML, Smith B, McLaughlin EM, Hade EM, et al
    Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancer.
    Gynecol Oncol. 2019 Feb 2. pii: S0090-8258(19)30068.
    Abstract    

    Abstract available

  191. LOOPIK DL, Bekkers RLM, Massuger LFAG, Melchers WJG, et al
    Justifying conservative management of CIN2 in women younger than 25years - A population-based study.
    Gynecol Oncol. 2019;152:82-86.
    Abstract    

    Abstract available

  192. LIANG J, Wolsiefer K, Zestcott CA, Chase D, et al
    Implicit bias toward cervical cancer: Provider and training differences.
    Gynecol Oncol. 2019 Feb 7. pii: S0090-8258(19)30055.
    Abstract    

    Abstract available

  193. EINSTEIN MH, Ndlovu N, Lee J, Stier EA, et al
    Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: A phase II study of the AIDS malignancy consortium.
    Gynecol Oncol. 2019 Feb 15. pii: S0090-8258(19)30065.
    Abstract    

    Abstract available

  194. XIA P, Huang M, Zhang Y, Xiong X, et al
    NCK1 promotes the angiogenesis of cervical squamous carcinoma via Rac1/PAK1/MMP2 signal pathway.
    Gynecol Oncol. 2019;152:387-395.
    Abstract    

    Abstract available

  195. CAMPOS NG, Maza M, Alfaro K, Gage JC, et al
    The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.
    Int J Gynaecol Obstet. 2019 Jan 31. doi: 10.1002/ijgo.12773.
    Abstract    

    Abstract available

  196. RISLEY C, Geisinger KR, Robinson JC, Stewart MW, et al
    Precancerous cervical lesions and HPV genotypes identified in previously unsatisfactory cervical smear tests after inexpensive glacial acetic acid processing.
    Int J Gynaecol Obstet. 2018 Oct 26. doi: 10.1002/ijgo.12699.
    Abstract    

    Abstract available

  197. HUANG Y, He Q, Xu K, Zhou J, et al
    A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
    Int J Gynecol Cancer. 2019 Feb 7. pii: ijgc-2018-000095.
    Abstract    

    Abstract available

  198. ANGELES MA, Baissas P, Leblanc E, Lusque A, et al
    Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence.
    Int J Gynecol Cancer. 2019 Feb 1. pii: ijgc-2018-000168.
    Abstract    

    Abstract available

  199. YANG L, Chen H
    Establishing the prognostic value of platelet-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2019 Feb 9. pii: ijgc-2018-000090.
    Abstract    

    Abstract available

  200. PARRA S, Oden M, Schmeler K, Richards-Kortum R, et al
    Low-Cost Instructional Apparatus to Improve Training for Cervical Cancer Screening and Prevention.
    Obstet Gynecol. 2019 Feb 4. doi: 10.1097/AOG.0000000000003140.
    Abstract    

    Abstract available

  201. SU X, Zhang L, Kang H, Zhang B, et al
    Mechanical, nanomorphological and biological reconstruction of earlystage apoptosis in HeLa cells induced by cytochalasin B.
    Oncol Rep. 2019;41:928-938.
    Abstract    

    Abstract available

  202. LI X, Wu X, Li Y, Cui Y, et al
    Promoter hypermethylation of SOX11 promotes the progression of cervical cancer in vitro and in vivo.
    Oncol Rep. 2019 Feb 1. doi: 10.3892/or.2019.6993.
    Abstract    

    Abstract available

  203. VAN DE SANDE AJM, Koeneman MM, Gerestein CG, Kruse AJ, et al
    TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
    BMC Cancer. 2018;18:655.
    Abstract    

    Abstract available

  204. COUVREUR K, Naert E, De Jaeghere E, Tummers P, et al
    Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates.
    BMC Cancer. 2018;18:1101.
    Abstract    

    Abstract available

  205. BASTA T, Knapp P, Blecharz P, Bodnar L, et al
    Current management of cervical cancer in Poland-Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations.
    PLoS One. 2019;14:e0209901.
    Abstract    

    Abstract available

  206. TORRES KL, Marino JM, Pires Rocha DA, de Mello MB, et al
    Self-sampling coupled to the detection of HPV 16 and 18 E6 protein: A promising option for detection of cervical malignancies in remote areas.
    PLoS One. 2018;13:e0201262.
    Abstract    

    Abstract available

  207. LE GM, Radcliffe K, Lyles C, Lyson HC, et al
    Perceptions of cervical cancer prevention on Twitter uncovered by different sampling strategies.
    PLoS One. 2019;14:e0211931.
    Abstract    

    Abstract available

  208. LECONTE BA, Szaniszlo P, Fennewald SM, Lou DI, et al
    Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer.
    PLoS One. 2018;13:e0203403.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;